Patients receiving omega-@s ( group @ ) had significantly lower levels of vitreal VEGF-A ( @ @ pg/mL ) when compared with group @ ( @ @ pg/mL ; P = @ ) and group @ ( @ @ pg/mL ; P = @ ) , but similar levels to group @ ( @ @ pg/mL ; P = @ ) .